Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Drops for IOP Spikes in Intravitreal Injection
NCT04868175Completed
- Sponsor
- The University of Hong Kong
- Start
- Oct 2019
- Primary completion
- Mar 2021
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of timolol maleate gel + placebo and travoprost in ocular hypertension (3 arms), sponsored by The University of Hong Kong. Primary endpoint: IOP effect of prophylactic IOP lowering eye drops. Started Oct 2019; status: completed.
02
Drugs
timolol maleate gel + placebotravoprost
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT04868175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04868175.